review
report
new
revers
approach
find
bioactiv
molecul
separ
target
compound
relat
plant
use
virtual
screen
immobil
enzym
polyclon
antibodi
molecularli
imprint
polym
find
separ
activ
compound
tcm
approach
faster
effici
tradit
timeconsum
approach
select
plant
separ
compound
follow
bioassay
guidanc
tradit
chines
medicin
tcm
see
glossari
rich
natur
compound
use
china
year
tcm
consid
natur
combinatori
chemic
librari
compar
synthet
one
tcm
present
divers
structur
bioactiv
less
toxic
therefor
repres
attract
sourc
new
activ
compound
drug
discoveri
convent
approach
find
activ
compound
tcm
involv
select
potenti
plant
isol
compound
follow
bioassay
guidanc
approach
play
import
part
drug
develop
howev
often
timeconsum
contain
fals
posit
see
outstand
issu
review
report
revers
approach
find
bioactiv
molecul
separ
target
compound
relat
plant
use
virtual
screen
immobil
enzym
polyclon
antibodi
molecularli
imprint
polym
mip
find
separ
activ
compound
tcm
quickli
effici
computeraid
drug
design
cadd
permeat
aspect
modern
drug
discoveri
allow
discoveri
new
candid
desir
biolog
activ
quickli
lower
cost
progress
applic
cadd
present
refer
till
articl
applic
cadd
tcm
owe
lack
relat
databas
qiao
et
al
develop
tcm
inform
system
includ
tcm
formul
databas
tcm
plant
databas
structur
databas
tcm
compon
fig
three
databas
link
structur
databas
contain
compound
isol
tcm
offer
basic
molecular
properti
optim
structur
compound
also
detail
inform
herb
origin
includ
basic
herbal
categori
eg
english
name
latin
name
famili
effect
part
clinic
effect
relat
formul
tcm
jiang
et
al
collabor
neotrid
technolog
ltd
see
tabl
develop
chines
natur
product
databas
cnpd
contain
natur
product
among
entri
check
cnpd
provid
structur
model
relat
plant
inform
tcm
properti
bioactiv
cadd
studi
deriv
tcm
typic
involv
virtual
screen
optim
lead
structur
establish
quantit
structureact
relationship
qsar
predict
druglik
predict
absorpt
distribut
metabol
eliminationtox
admet
comput
aid
molecular
structur
elucid
first
inform
regard
herb
mixtur
relat
specif
diseas
retriev
tcm
formul
databas
second
structur
subset
ingredi
relat
specif
diseas
construct
search
origin
structur
plant
consist
tcm
formul
third
subset
filter
via
virtual
screen
sever
screen
method
cadd
exampl
molecular
dock
use
studi
interact
bioactiv
compound
target
enzym
target
structur
known
pharmacophor
search
use
search
candid
compound
specif
pharmacophor
group
candid
compound
avail
subject
bioactiv
test
mostli
bioactiv
test
must
appli
fraction
extract
plant
contain
candid
compound
compound
higher
activ
isol
hit
rate
screen
activ
compound
tcm
databas
correspondingli
higher
chemic
databas
rare
case
natur
product
like
taxol
becom
drug
without
modif
usual
howev
structur
activ
compound
need
modifi
cadd
eg
qsar
dock
synthes
qiao
et
al
appli
method
identifi
new
potenti
inhibitor
hepat
c
viru
hcv
proteas
crystal
structur
solv
kim
et
al
use
design
target
first
studi
interact
compound
target
proteas
via
molecular
dock
modul
also
develop
group
sever
high
score
candid
compound
select
accord
energi
geometri
match
final
compound
extract
respect
plant
subject
bioactiv
test
structur
modifi
improv
bioactiv
result
nine
compound
ic
mmml
bind
energi
calcul
molecular
mechanicspossionbolzman
surfac
area
mmpbsa
method
result
show
bind
energi
parallel
ic
jiang
et
al
perform
dock
screen
see
tabl
primari
druglik
analysi
use
cnpd
model
eukaryot
k
channel
got
potenti
potassium
ion
k
channel
blocker
bioassay
test
four
compound
found
potent
extens
use
ik
blockertetraethlammonion
tea
therefor
compound
might
replac
tea
select
k
blocker
neurobiolog
research
rapid
screen
activ
compound
directli
tcm
rapid
screen
enzym
inhibitor
key
method
find
drug
lead
common
method
use
highthroughput
screen
ht
enzym
inhibitor
involv
glossari
facm
combin
frontal
affin
chromatographi
mass
spectrometri
detect
base
continu
infus
ligand
protein
target
immobil
onto
solid
support
column
elut
ligand
detect
ms
ligand
flow
column
bind
target
differ
affin
breakthrough
volum
ligand
depend
affin
ligand
target
eq
basic
equat
frontal
affin
chromatographi
also
shown
form
v
elut
volum
analyt
c
concentr
analyt
v
elut
volum
control
substanc
affin
l
total
amount
immobil
ligand
k
dissoci
constant
v
approach
maximum
valu
v
c
k
c
neglibl
small
compar
k
follow
equat
obtain
mipsp
misp
basic
concept
applic
mip
solid
phase
extract
misp
chromatograph
paramet
tune
misp
column
trap
analyt
group
structur
relat
compound
wherea
interf
compon
sampl
matrix
wash
without
retent
tcm
tradit
chines
medicin
tcm
medic
scienc
govern
theori
practic
tradit
medicin
includ
chines
medic
pharmacologyherbalog
acupunctur
massag
qigong
articl
tcm
relat
tradit
chines
medicin
herb
wwwdrugdiscoverytodaycom
colorimetr
fluorimetr
assay
howev
numer
difficulti
associ
ht
assay
develop
enzym
receptor
repres
common
drug
target
target
base
drug
discoveri
import
strategi
develop
new
agent
tcm
prepar
mixtur
larg
number
compound
activ
target
may
unknown
low
concentr
background
activ
speci
screen
process
might
lead
fals
posit
result
sum
activ
mani
weakli
activ
compound
case
bioactiv
guid
isol
screen
biochromatographi
wide
use
screen
activ
compound
tcm
wang
et
al
use
immobil
human
serum
albumin
hba
acid
glycoprotein
agp
stationari
phase
screen
activ
compound
tcm
use
high
perform
liquid
chromatographi
hplc
et
al
appli
biomembran
chromatographi
immobil
biolog
cell
membran
silica
support
studi
tcm
although
chromatographi
one
main
techniqu
use
studi
tcm
current
chromatographi
techniqu
still
unsatisfactori
sinc
difficult
distinguish
bioactiv
compon
peak
peak
meet
requir
ht
affin
base
screen
use
frontal
affin
chromatographi
coupl
mass
spectrometri
facm
see
glossari
direct
faster
method
screen
activ
compound
tcm
quick
effici
screen
activ
compound
low
concentr
also
avoid
interfer
activ
compound
facm
establish
schreimer
applic
facm
broad
rang
biolog
system
togeth
labelfre
oper
rel
high
throughput
abil
rank
ligand
determin
dissoci
constant
k
make
facm
univers
tool
enabl
conveni
effici
screen
identif
new
potenti
drug
lead
tcm
contain
mani
unknown
compound
differ
unknown
concentr
featur
labelfre
oper
rel
high
throughput
abil
rank
ligand
breakthrough
volum
relat
ligand
concentr
c
k
make
facm
appeal
techniqu
screen
activ
compound
tcm
see
glossari
zhu
et
al
develop
effici
straightforward
procedur
analyz
bind
properti
differ
inhibitor
epiderm
growth
factor
receptor
egfr
combin
fac
marin
electrospray
ioniz
mass
spectrometri
see
tabl
polyclon
antibodi
pcab
use
system
pcab
rais
piceatannol
link
bovin
serum
albumin
bsa
coval
bound
chromatograph
pack
mimick
egfr
six
inhibitor
includ
halfantigen
recogn
crude
extract
caragana
jubata
correspond
dissoci
constant
k
six
analyt
estim
contrast
respect
bioactiv
ic
bind
affin
pcab
analyt
stronger
factor
k
smaller
wherea
bioactiv
molecul
higher
ic
smaller
result
could
conclud
recognit
base
pcab
effici
analyt
higher
activ
retain
affin
column
longer
luo
et
al
report
applic
facm
screen
activ
compound
extract
phylantu
urinaria
l
base
immobil
pcab
use
mimic
hepat
c
viru
hcv
proteas
mani
articl
publish
applic
facm
immobil
enzym
screen
activ
compound
chemic
librari
first
report
use
facm
tcm
made
yi
et
al
use
facm
base
immobil
surfac
spike
protein
sarcov
screen
speci
tcm
tetraogalloybdglucos
tgg
luteolin
bind
avidli
surfac
spike
protein
sarscov
thu
interfer
entri
viru
host
cell
use
wildtyp
sarscov
infect
system
confirm
tgg
exhibit
promin
antisarscov
activ
effect
concentr
mmml
select
index
techniqu
molecular
imprint
introduc
wulff
molecularli
imprint
polym
extens
crosslink
polym
contain
specif
recognit
site
predetermin
select
analyt
interest
techniqu
involv
complex
solut
target
molecul
templat
function
monom
either
coval
noncoval
bond
follow
polymer
reaction
excess
crosslink
remov
templat
leav
behind
specif
recognit
site
complementari
templat
term
shape
size
function
polym
network
recognit
site
enabl
imprint
polym
use
mimic
enzym
receptor
antibodi
screen
variou
kind
compound
mixtur
abund
interfer
mani
review
summar
develop
mip
cover
mani
aspect
sorbent
sampl
preconcentr
stationari
phase
separ
bioassay
biosensor
mimic
enzym
receptor
catalyst
theoret
activ
inhibitori
compound
adopt
templat
abl
result
imprint
polym
would
screen
differ
inhibitor
microcav
correspond
polym
would
simul
bind
pocket
enzym
success
owe
templat
higher
bioactiv
could
conjug
bind
pocket
tightli
term
shape
size
function
group
mip
use
techniqu
screen
separ
activ
compound
tcm
steroid
receptor
mimic
folat
receptor
mimic
adrenoreceptor
mimic
made
mip
use
screen
bioactiv
compound
synthet
librari
dong
et
al
use
mip
solid
phase
extract
misp
see
glossari
ephedrin
chromatograph
separ
marin
oxymartin
chines
ephedra
li
et
al
appli
fisetinimprint
polym
separ
fisetin
analogu
quercetin
tcm
use
chromatographi
studi
behavior
mip
mip
coupl
ms
see
tabl
prepar
use
e
piceatannol
natur
potenti
antiegfr
inhibitor
templat
function
monom
zhu
et
al
crude
extract
herb
load
mip
column
bind
test
two
differ
compound
besid
templat
specif
recogn
polym
identifi
butein
quercetin
possess
potent
antiegfr
tyrosin
kinas
activ
ic
valu
mmml
respect
affin
select
inhibitor
anoth
three
compound
coexist
templat
herb
evalu
chromatograph
mode
first
time
affin
mip
investig
correl
bioactiv
analyt
work
demonstr
feasibl
use
mip
screen
separ
activ
compound
onlin
identif
inhibitor
directli
crude
extract
herb
would
help
discov
lead
compound
drug
candid
approach
luo
et
al
carri
effici
separ
base
mip
appli
phyllanthu
urinaria
l
sever
novel
inhibitor
hepat
c
viru
hcv
proteas
screen
xie
et
al
use
coupl
liquidphas
chromatographi
mass
spectrometri
lcm
system
consist
combin
column
mip
ms
detector
affinit
separ
onlin
identif
antitumor
compon
harmin
harmalin
methanol
extract
peganum
nigellastrum
seed
target
bind
capac
mip
evalu
frontal
chromatographi
isol
analyt
urin
plasma
bile
anim
tissu
import
pharmacokinet
studi
studi
sampl
appli
directli
mip
antiquercetin
mip
evid
hydrophob
matrix
synthes
use
acrylamid
aa
function
monom
hydroxymethi
butanol
trimethacryl
trim
cross
linker
xie
et
al
affin
select
evalu
liquid
chromatographi
bind
site
dissoci
constant
measur
frontal
chromatographi
result
show
mipsp
could
use
direct
clean
biolog
sampl
analysi
function
compon
vivo
origin
extract
medicin
herb
therefor
mip
import
tool
studi
pharmacokinet
tcm
current
estim
approxim
plant
speci
exist
natur
speci
higher
plant
identifi
plant
known
medic
properti
howev
less
plant
investig
phytochem
pharmacolog
point
view
far
medic
plant
found
china
small
amount
systemat
investig
necessari
us
carri
drug
discoveri
research
use
avail
inform
knowledg
develop
new
approach
screen
separ
activ
compound
directli
tcm
cadd
use
approach
util
inform
knowledg
find
optim
predict
properti
activ
compound
main
goal
cadd
base
tcm
limit
number
compound
requir
experiment
test
maxim
hit
rate
timeconsum
obtain
pure
compound
tcm
use
strategi
use
hierarch
multipl
filter
databas
screen
report
wang
et
al
novel
applic
immobil
enzym
pcab
mip
tcm
effect
recognit
activ
compound
immers
immers
afford
us
new
approach
discoveri
lead
compound
drug
candid
benefici
drug
develop
immobil
enzym
pcab
method
combin
facm
use
screen
although
method
similarli
advanc
featur
recogn
activ
compound
pcab
mimic
enzym
less
recognit
abil
immobil
enzym
immobil
enzym
avail
suitabl
screen
pcab
use
altern
method
mip
use
mimic
enzym
receptor
direct
screen
separ
onlin
identif
activ
compound
tcm
speed
drug
discoveri
base
tcm
mip
proven
feasibl
mimic
term
physic
robust
resist
elev
temperatur
pressur
inert
toward
acid
base
metal
ion
organ
solvent
materi
well
employ
variou
kind
sampl
includ
biolog
cadd
immobil
enzym
pcab
mip
complementari
integr
multifacet
platform
contribut
earli
drug
discoveri
process
first
virtual
screen
use
find
potenti
activ
compound
activ
fraction
part
contain
potenti
compound
subject
screen
separ
activ
compound
mip
one
singl
step
also
screen
activ
compound
firstli
use
immobil
enzym
pcab
separ
activ
compound
use
mip
pcab
mip
use
find
substitut
patent
medicin
import
yet
expens
tcm
although
tcm
proven
use
mani
peopl
throughout
histori
sometim
neglect
western
research
owe
constitu
mechan
tcm
unclear
present
differ
concept
ill
tcm
complex
system
time
consum
difficult
separ
identifi
constitu
revers
approach
may
use
find
activ
compound
immers
interfer
synergi
import
fundament
mechan
tcm
involv
multipl
target
pathway
therefor
need
develop
approach
synergi
studi
hit
rate
virtual
screen
base
tcm
databas
correspond
higher
chemic
databas
featur
label
free
oper
abil
rank
ligand
break
volum
unrel
ligand
concentr
c
k
avail
multipl
target
make
facm
effici
approach
screen
activ
compound
tcm
sometim
conform
chang
consid
process
